BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9290964)

  • 1. Delayed resolution versus treatment failure in paucibacillary leprosy patients under six months fixed duration multidrug therapy.
    Job CK; Jayakumar J; Aschhoff M
    Indian J Lepr; 1997; 69(2):131-42. PubMed ID: 9290964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinico-pathological study of multidrug regimen in paucibacillary leprosy.
    Kar PK; Jha PK; Panayach JS; Snehi PS
    Indian J Lepr; 1988 Apr; 60(2):235-41. PubMed ID: 3192972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fixed duration MDT in paucibacillary leprosy.
    Mathai R; George S; Jacob M
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):237-41. PubMed ID: 2071980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of multidrug therapy in paucibacillary leprosy.
    Kar PK; Sohi AS
    J Indian Med Assoc; 1989 Feb; 87(2):34-6. PubMed ID: 2674283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug therapy in paucibacillary leprosy--a five year experience.
    Grugni A; Nadkarni NJ; Kini MS
    Indian J Lepr; 1988 Oct; 60(4):589-92. PubMed ID: 3253339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paucibacillary multidrug therapy in leprosy. 7 1/2 years experience.
    Kaur S; Sharma VK; Basak P; Kaur I
    Indian J Lepr; 1992; 64(2):153-61. PubMed ID: 1607713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapses in paucibacillary leprosy after MDT--a clinical study.
    Grugni A; Nadkarni NJ; Kini MS; Mehta VR
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):19-24. PubMed ID: 2319185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of multidrug therapy in paucibacillary leprosy patients; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):436-44. PubMed ID: 1474282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse rate in paucibacillary leprosy patients after multidrug therapy in North Arcot District.
    Ekambaram V; Rao MK
    Indian J Lepr; 1991; 63(1):34-42. PubMed ID: 1919088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinico-histopathological study of multidrug therapy in indeterminate leprosy.
    Kar PK; Jha PK; Panaych JS; Snehi PS
    Indian J Lepr; 1990; 62(1):98-103. PubMed ID: 2358708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug therapy for treatment of paucibacillary leprosy in western Kenya--preliminary communications.
    Orege PA; Obura M; Okelo C; Okuku P; Makokha S; Nyawalo J
    East Afr Med J; 1990 Sep; 67(9):632-9. PubMed ID: 2253572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with multidrug therapy in paucibacillary leprosy.
    Bhate RD; Gupta CM; Chattopadhyay SP; Singh IP
    Indian J Lepr; 1986; 58(2):244-50. PubMed ID: 3805797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapeutic trials with different regimens containing rifampicin in paucibacillary type of leprosy cases--a preliminary report.
    Katoch K; Ramu G; Ramanathan U
    Indian J Lepr; 1985; 57(3):499-506. PubMed ID: 3831087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four-year follow-up results of a WHO-recommended multiple-drug regimen in paucibacillary leprosy patients in Malawi.
    Boerrigter G; Pönnighaus JM; Fine PE; Wilson RJ
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):255-61. PubMed ID: 2071983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paucibacillary leprosy: a comparative study of different schedules of multidrug therapy.
    Ramakrishnan KR; Arora PN; Aggarwal SK; Ramachandra S
    Indian J Lepr; 1988 Oct; 60(4):542-8. PubMed ID: 3253333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of paucibacillary leprosy with a regimen containing rifampicin, dapsone and prothionamide.
    Katoch K; Natarajan M; Bhatia AS; Yadav VS
    Indian J Lepr; 1992; 64(3):303-12. PubMed ID: 1431319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary assessment of multidrug therapy in leprosy patients in Western Samoa.
    Paksoy N; Levi V
    N Z Med J; 1989 Nov; 102(879):589-91. PubMed ID: 2812597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological changes in tuberculoid leprosy after fixed duration multidrug therapy for six months.
    Lavania RK; Girdhar A; Girdhar BK; Desikan KV
    Acta Leprol; 1990; 7(2):169-74. PubMed ID: 2220301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three regimens containing rifampin for treatment of paucibacillary leprosy patients.
    Katoch K; Ramu G; Ramanathan U; Desikan KV
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):1-8. PubMed ID: 3559333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapses in paucibacillary patients after treatment with three short-term regimens containing rifampin.
    Katoch K; Ramanathan U; Natrajan M; Bagga AK; Bhatia AS; Saxena RK; Ramu G
    Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):458-64. PubMed ID: 2746075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.